V
Vitux Group
Solution provider and manufacturer providing private label products for the nutraceutical and dietary supplement industry worldwide
About Vitux Group
Concordix, a brand under Vitux CDMO, specializes in producing nutritional supplements in the form of chewable Smart Chews. These supplements are designed to replicate the natural process of nutrient intake through chewing, swallowing, and digesting, making it easier for consumers to receive essential nutrients. Concordix serves a diverse range of clients, including international partners in the nutraceutical industry, such as Amway Nutrilite and Childlife Essentials. The company operates in the health and wellness market, focusing on providing innovative solutions for nutritional supplementation. Concordix's business model revolves around contract manufacturing, where they produce customized supplements for their partners. Revenue is generated through these manufacturing contracts and partnerships. The company recently expanded its operations by opening a new plant in Windsor, Canada, to meet growing demand. Concordix is committed to continuous innovation and staying at the forefront of the nutraceutical industry.
Source: Dealroom company dataAt a glance
- Founded
- 2010
- Headquarters
- Oslo, Norway
- Sector
- Food
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Investinor
Norinnova Invest
Innovation Norway
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vitux Group on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vitux Group on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.